EN
HI
Fortis Healthcare Share price
FORTIS
929
22.85 (2.52%)NSE
BSE
Last updated on 14 Aug, 2026 | 15:56 IST
Fortis Healthcare share price chart
Fortis Healthcare Share Key Metrics
Volume
15.36 L
Market Cap
70135.61 CR
LTQ@LTP
14@929.00
ATP
914.33
Var Margin
14.38 %
Circuit Range
836.1-1021.9
Delivery %
53.88 %
Value
140.41 CR
ASM/GSM
No
Market Lot
1
Summary
FORTIS stock price is ₹929 as of 16 Aug, 2026. The stock intraday movement has stayed between ₹897.60 and ₹929.00, while Fortis Healthcare share price 52 week high low is ₹766.80 & ₹1104.30.
In terms of trading activity, FORTIS share price has recorded a volume of 15,35,625 shares. The Fortis Healthcare has a market cap of ₹754958148. The stock’s Average Traded Price (ATP) stands at ₹914.33, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 14 @ ₹929.00.
The Fortis Healthcare upper circuit limit is ₹1021.90 & The Fortis Healthcare lower circuit limit is ₹836.10, with a Value of ₹140.41 CR. The Delivery Percentage for the day is 53.88%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Fortis Healthcare Resistance and Support
Pivot 899.98
Resistance
First Resistance
912.31
Second Resistance
918.48
Third Resistance
930.81
Support
First Support
893.81
Second Support
881.48
Third Support
875.31
Fortis Healthcare Futures & Options
929
22.85 (2.52%)
Fortis Healthcare Option Chain
View Price, OI, Greeks & More...
25AUG26
925.15
18.80 (2.07%)
29SEP26
932.10
20.55 (2.25%)
27OCT26
934.20
20.20 (2.21%)
FORTIS|25AUG26 CE 920.00
17.25
6.75 (64.29%)
FORTIS|25AUG26 PE 930.00
16.6
-14.05 (-45.84%)
Fortis Healthcare Shareholding Pattern
View More- 2018-19
- 2019-20
- 2020-21
- 2021-22
- 2022-23
- 2023-24
- 2024-25
- 2025-26
- 2026-27
Total Promoters
Segment
Percent
Total Promoters
31.17%
Mutual Fund
25.81%
Insurance
4.58%
Foreign Institutional Investors
25.2%
Domestic Institutional Investors
1.84%
Retail
11.4%
Others
0%
Total Promoters
MAR '26
31.17%
JUN '26
31.17%
Fortis Healthcare Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-06 | Quarterly Results |
| 2026-05-22 | Audited Results & Final Dividend |
| 2026-02-13 | Quarterly Results |
| 2025-11-11 | Quarterly Results |
| 2025-08-06 | Quarterly Results & Others |
| 2025-05-20 | Audited Results & Final Dividend |
| 2025-02-07 | Quarterly Results |
| 2024-11-08 | Quarterly Results |
| 2024-10-09 | Others |
| 2024-08-30 | To consider Fund Raising |
| 2024-08-06 | Quarterly Results |
| Ex Date | Record Date | |
|---|---|---|
| 2026-07-24 | 2026-07-24 | View More |
Fortis Healthcare News
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fortis Healthcare announced strong Q1 FY27 results with consolidated revenue increasing 17.5% to Rs.2,545 cr and PAT growing 2.3% to Rs.273 cr. The company also signed an O&M agreement for a 300-bedded hospital in Cuttack and plans to add 1,800 new beds.
Aug 06 2026 19:32:18
Fortis Healthcare Ltd - 532843 - Board Meeting Outcome for Outcome Of Board Meeting
Board approved Q1 FY27 consolidated financial results with revenue of ₹2,545.03 crores, up 17.46% YoY, and net profit of ₹272.80 crores, up 2.25% YoY. Additionally, B S R & Co. LLP was appointed as tax auditors for FY26.
Aug 06 2026 19:01:02
Fortis Healthcare Ltd - 532843 - Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.
Fortis Healthcare's material subsidiary, Agilus Diagnostics Ltd., board approved an intra-group restructuring by merging its wholly-owned subsidiaries Agilus Pathlabs Private Ltd. and DDRC Agilus Pathlabs Ltd. The Scheme of Arrangement involves no cash consideration and aims to streamline the group structure.
Aug 05 2026 17:23:02
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Fortis Healthcare will hold a conference call on August 7, 2026, at 11:00 AM IST to discuss its Q1 FY27 un-audited financial results. No UPSI will be shared during the meet.
Jul 31 2026 16:12:34
Fortis Healthcare Ltd - 532843 - Board Meeting Intimation for Approval Of Un-Audited Financial Results (Standalone & Consolidated) For The Quarter Ended June 30, 2026.
Fortis Healthcare announced that its Board of Directors will meet on August 6, 2026. The primary agenda is to consider and approve the financial results for the quarter ended June 30, 2026.
Jul 30 2026 17:51:44
Fortis Healthcare Ltd - 532843 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Fortis Healthcare's subsidiary, Agilus Diagnostics, has appointed Vijender Singh as its new Managing Director & Chief Executive Officer, effective July 20, 2026. Singh has over three decades of leadership experience in the diagnostics and healthcare sectors.
Jul 20 2026 15:18:07
Fortis Healthcare Ltd - 532843 - Record Date For Payment Of Dividend
Fortis Healthcare fixed July 24, 2026, as the Record Date for its final dividend. This dividend of ₹1 per equity share for FY26 is subject to approval at the upcoming AGM.
Jul 17 2026 18:29:36
Read More
Fortis Healthcare Management
| Name | Position |
|---|---|
| Satyendra Chauhan | Company Secretary & Compliance Officer |
| Leo Puri | Chairman |
Fortis Healthcare Similar Stocks
Laurus Labs Ltd.
1787.30
-64.40 (3.48%)
Max Healthcare Institute Ltd.
1008.60
-4.70 (0.46%)
Aurobindo Pharma Ltd.
1622.10
-41.30 (2.48%)
Manipal Health Enterprises Ltd.
706.95
11.65 (1.68%)
Aster DM Quality Care Ltd.
822.35
-1.95 (0.24%)
Biocon Ltd.
417.00
-3.00 (0.71%)
Alkem Laboratories Ltd.
5368.00
-81.50 (1.50%)
Glenmark Pharmaceuticals Ltd.
2318.40
-1.60 (0.07%)
Abbott India Ltd.
27060.00
-560.00 (2.03%)
Anthem Biosciences Ltd.
890.10
15.20 (1.74%)
Fortis Healthcare FAQs
The Buying Price of Fortis Healthcare share is 929 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Fortis Healthcare stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Fortis Healthcare, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Fortis Healthcare shares is 67.36. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Fortis Healthcare shares is 6.95. Useful to assess the stock's value relative to its book value.
To assess Fortis Healthcare’s valuation compare Sector P/E, P/B which are 54.06 & -14.52 with sector averages, along with growth rates and financial metrics.
The Market Cap of Fortis Healthcare is 70135.61 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Fortis Healthcare share price is 1104.30 & 766.80. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Fortis Healthcare belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year
Auto Square Off Charges
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC
13 Lakh+ Clients
Expert-Backed
Premium Tools

Invest in FORTIS
Account Opening Fee
AMC for 1st Year
Auto Square Off Charges
Call & Trade
Open a Free Demat Account
+ Free 1st Year AMC
+ Free 1st Year AMC